Related Experiment Video
Updated: Apr 27, 2026

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
Published on: February 13, 2013
Differentially expressed plasma microRNAs and the potential regulatory function of Let-7b in chronic thromboembolic
Lijuan Guo1, Yuanhua Yang1, Jie Liu2
1Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, P.R. China; Beijing Institute of Respiratory Medicine, Capital Medical University, Beijing, P.R. China.
Abstract:
Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease characterized by misguided thrombolysis and remodeling of pulmonary arteries. MicroRNAs are small non-coding RNAs involved in multiple cell processes and functions. During CTEPH, circulating microRNA profile endued with characteristics of diseased cells could be identified as a biomarker, and might help in recognition of pathogenesis. Thus, in this study, we compared the differentially expressed microRNAs in plasma of CTEPH patients and healthy controls and investigated their potential functions. Microarray was used to identify microRNA expression profile and qRT-PCR for validation. The targets of differentially expressed microRNAs were identified in silico, and the Gene Ontology database and Kyoto Encyclopedia of Genes and Genomes pathway database were used for functional investigation of target gene profile. Targets of let-7b were validated by fluorescence reporter assay. Protein expression of target genes was determined by ELISA or western blotting. Cell migration was evaluated by wound healing assay. The results showed that 1) thirty five microRNAs were differentially expressed in CTEPH patients, among which, a signature of 17 microRNAs, which was shown to be related to the disease pathogenesis by in silico analysis, gave diagnostic efficacy of both sensitivity and specificity >0.9. 2) Let-7b, one of the down-regulated anti-oncogenic microRNAs in the signature, was validated to decrease to about 0.25 fold in CTEPH patients. 3) ET-1 and TGFBR1 were direct targets of let-7b. Altering let-7b level influenced ET-1 and TGFBR1 expression in pulmonary arterial endothelial cells (PAECs) as well as the migration of PAECs and pulmonary arterial smooth muscle cells (PASMCs). These results suggested that CTEPH patients had aberrant microRNA signature which might provide some clue for pathogenesis study and biomarker screening. Reduced let-7b might be involved in the pathogenesis of CTEPH by affecting ET-1 expression and the function of PAECs and PASMCs.
Insights
A distinct microRNA signature in the blood of patients with chronic thromboembolic pulmonary hypertension (CTEPH) could serve as a diagnostic biomarker. Reduced levels of let-7b may contribute to CTEPH development by impacting cell function.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive vascular disease.
- MicroRNAs (miRNAs) are key regulators of cellular processes and potential disease biomarkers.
- Circulating miRNA profiles may reflect disease state and offer insights into CTEPH pathogenesis.
Purpose of the Study:
- To identify differentially expressed miRNAs in CTEPH patients compared to healthy controls.
- To investigate the functional roles of these miRNAs and their targets in CTEPH.
- To explore the diagnostic potential of miRNA signatures in CTEPH.
Main Methods:
- Microarray analysis for miRNA profiling.
- Quantitative reverse transcription PCR (qRT-PCR) for validation.
- In silico target prediction, Gene Ontology, and KEGG pathway analysis for functional enrichment.
- Fluorescence reporter assays, ELISA, western blotting, and wound healing assays for target validation and functional assessment.
Main Results:
- Thirty-five miRNAs were differentially expressed in CTEPH patients, with a 17-miRNA signature demonstrating high diagnostic accuracy (>0.9 sensitivity and specificity).
- Let-7b, an anti-oncogenic miRNA, was significantly downregulated (approx. 0.25 fold) in CTEPH patients.
- Endothelin-1 (ET-1) and Transforming Growth Factor Beta Receptor 1 (TGFBR1) were identified as direct targets of let-7b, and altered let-7b levels affected ET-1/TGFBR1 expression and cell migration in pulmonary arterial cells.
Conclusions:
- CTEPH patients exhibit an aberrant circulating miRNA profile that may aid in biomarker screening and understanding disease pathogenesis.
- Reduced let-7b levels are implicated in CTEPH pathogenesis, potentially through modulation of ET-1 expression and pulmonary arterial cell function.
More Related Videos
07:23Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs